Skip to main content

5-Amino-1MQ vs Glutathione (GSH)

Both 5-Amino-1MQ and Glutathione (GSH) are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.

5-Amino-1MQ

Evidence C+

5-Amino-1-Methylquinolinium

A small-molecule NNMT inhibitor that has produced fat loss and improved muscle stem-cell function in obese rodents. No human RCTs yet.

View full 5-Amino-1MQ profile →

Glutathione (GSH)

Evidence B

Reduced L-Glutathione

Technically a tripeptide (γ-glutamyl-cysteinyl-glycine) and the body's primary antioxidant. Often grouped with peptide therapy in IV/compounded form for liver support and oxidative stress.

View full Glutathione (GSH) profile →

Side-by-Side

Attribute5-Amino-1MQGlutathione (GSH)
Evidence GradeC+B
FDA StatusNot FDA-approved — small-molecule research compound (NNMT inhibitor)Not FDA-approved as therapeutic — sold as supplement; intravenous use compounded
Typical Dose50–150 mg orally daily (research-only)200–600 mg sublingual / 600–2400 mg IV (compounded)
Clinics Indexed31312
Categoriesfat-loss, longevityantioxidant, longevity

Key reported benefits — 5-Amino-1MQ

  • NNMT inhibition
  • Fat-mass reduction (preclinical)
  • Muscle stem-cell support

Key reported benefits — Glutathione (GSH)

  • Master antioxidant
  • Liver detoxification support
  • Oxidative stress reduction

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons